ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 392

$481K Total Retail Price of All Prescriptions

Rank: 17 out of 392

395 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 6,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
LISINOPRIL 384 335 1 1
SIMVASTATIN 275 247 2 2
LEVOTHYROXINE SODIUM 265 202 3 3
FUROSEMIDE 263 232 4 6
AMLODIPINE BESYLATE 260 239 5 5
ATORVASTATIN CALCIUM 209 162 6 10
METOPROLOL TARTRATE 178 155 7 8
WARFARIN SODIUM 175 157 8 12
METOPROLOL SUCCINATE 156 137 9 13
HYDROCODONE-ACETAMINOPHEN 145 58 S3 10 14
OMEPRAZOLE 144 107 11 4
CITALOPRAM HBR 134 90 12 15
TRAMADOL HCL 126 69 13 25
LOVASTATIN 123 102 14 23
METFORMIN HCL 104 76 15 9
RANITIDINE HCL 104 86 15 31
ALLOPURINOL 95 81 17 38
ROPINIROLE HCL 94 93 18 82
GABAPENTIN 89 67 19 18
ISOSORBIDE MONONITRATE ER 87 87 20 67
PLAVIX 80 73 21 96
PREDNISONE 78 56 22 39
HYDROCHLOROTHIAZIDE 78 72 22 7
ALENDRONATE SODIUM 77 68 24 42
TAMSULOSIN HCL 76 61 25 37
PROAIR HFA 76 47 25 36
CLOPIDOGREL 74 63 27 70
MELOXICAM 74 63 27 62
POTASSIUM CHLORIDE 69 69 29 30
SERTRALINE HCL 69 67 29 19
ADVAIR DISKUS 69 63 29 32
ATENOLOL 67 64 32 11
TRAZODONE HCL 65 54 33 22
LANTUS 61 41 34 41
CIPROFLOXACIN HCL 60 47 35 85
FLUTICASONE PROPIONATE 58 44 36 45
DONEPEZIL HCL 58 46 36 29
ZOLPIDEM TARTRATE 53 42 38 21
SPIRIVA 53 52 38 43
NEXIUM 53 24 38 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.